Bioventus (BVS) Change in Working Capital (2020 - 2022)
Bioventus' (BVS) quarterly Change in Working Capital came in at $1.1 million in Q2 2022, down 87.62% on a YoY basis from $9.2 million in Q2 2021, and up 59.27% quarter-over-quarter from $712000.0 in Q4 2021.
Analysis
Bioventus (BVS) Change in Working Capital (2020 - 2022) Analysis & Trends
Bioventus (BVS) has reported Change in Working Capital for 3 consecutive years, with $1.1 million the latest figure, recorded in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Working Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.92 Bn | 176.31 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.64 Bn | 122.42 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.92 Bn | 109.10 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.39 Bn | 101.91 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 64.88 Bn | 64.34 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.66 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.24 Bn | 31.79 Bn | 1.68 Bn | -60.00 Mn |
| 8 | Dexcom | 32.12 Bn | 30.18 Bn | 830.00 Mn | - |
| 9 | Steris | 20.83 Bn | 20.35 Bn | 684.20 Mn | - |
| 10 | Bioventus | 902.66 Mn | 873.20 Mn | 105.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 2, 2022 | 1.13 Mn |
| Oct 2, 2021 | 712,000.00 |
| Jul 3, 2021 | 3.85 Mn |
| Apr 3, 2021 | 9.16 Mn |
| Sep 26, 2020 | -2.80 Mn |
| Jun 27, 2020 | 1.24 Mn |
| Mar 28, 2020 | -369,000.00 |